Zanubrutinib Label Expands to Include RR Follicular Lymphoma Zanubrutinib Label Expands to Include RR Follicular Lymphoma
The Bruton ' s kinase inhibitors new follicular lymphoma indication is for combination use with obinutuzumab.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news